Hodgkin Lymphoma (HL)

Phase 3 EuroNet-PHL-LP1: complete resection alone gives 79.5% five-year event-free survival in paediatric early-stage nodular lymphocyte-predominant Hodgkin lymphoma

In the prospective phase 3 EuroNet-PHL-LP1 trial, patients under 18 with stage IA/IIA nodular lymphocyte-predominant Hodgkin lymphoma who underwent complete lymph node resection followed by active surveillance had a five-year event-free survival of 79.5% (78 of 247 eligible patients). Those with unr…